Opioid Use Disorder: Board Review (2025-2026 Recording)

This session provides a focused, case-based review of opioid use disorder and its management across clinical settings, including key concepts in epidemiology, pharmacology, and diagnostic criteria, aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas.

What This Covers
• Epidemiology, patterns of use, and evolving trends in the opioid epidemic
• Pharmacology and diagnostic criteria for opioid use disorder
• The role of stigma in shaping clinical care and patient outcomes
• Recognition and management of opioid intoxication, withdrawal, and overdose
• Medications for opioid use disorder, including methadone, buprenorphine, and naltrexone
• Practical approaches to medication initiation, titration, and treatment selection across care settings
• Integration of harm reduction and overdose prevention strategies
• Management of co-occurring conditions, including chronic pain, in patients with opioid use disorder

How This Resource Is Used
This session is designed for on-demand learning and targeted content review. It can be used to reinforce specific knowledge areas or as part of structured board preparation.

	Natalie Buslach, MD Dr. Buslach is an Assistant Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. She serves as Medical Director of the Bridge Clinic at CFCC and Co‑Director of the Interdisciplinary Substance Use Disorder Fellowship.
	Matt Holm, MD Dr. Holm is an Assistant Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. He serves as Associate Program Director of the Addiction Medicine Fellowship.
	Laila Khalid, MD MPH Dr. Khalid is an Associate Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. She serves as Program Director of the Addiction Medicine Fellowship and holds leadership roles in the Buprenorphine Treatment Network, Opioid Overdose Prevention Program, and chronic pain care.
	Ruchi Shah, DO Dr. Shah is an Assistant Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. She serves as Medical Director of the Addiction Medicine Consult Service at Wakefield Hospital.
	Melissa Stein, MD Dr. Stein is Medical Director of the Division of Services for Addiction at Montefiore Medical Center and an Associate Professor of Medicine and Psychiatry & Behavioral Science at Albert Einstein College of Medicine. She also provides clinical care through Montefiore-affiliated programs, including the Port Morris Wellness Center.

To support a meaningful learning experience and recognize your participation:

The evaluation will become available after you have viewed the video in its entirety
We encourage you to complete the evaluation to reflect on the content and provide valuable feedback

Access Period
Access available through November 30, 2027 (aligned with the addiction medicine board exam cycle).

Recording Release Cycle
ACAAM releases updated recorded sessions each July based on the prior academic year’s didactic series. These recordings are available for a limited time and are retired on June 30 of the following year as new content is released.

Board Review Core Substances – Exam Access
Access to this recording extends beyond the standard annual cycle. Learners will retain access through November 30, 2027, aligned with the addiction medicine board examination cycle.